biotechnology stocks and certain resource developers are the main exclusion when it comes to revenue. e.g. moderna and novavax have zero revenue but are valued in the tens of billions combined, all on the potential of the drugs/vaccines. Bellevue and degrey gold developers have zero revenue but are valued at a billion each.
This isnt a biotech firm. more like a volpara which has revenue and does jack all day in day out.
Research, page-139
-
- There are more pages in this discussion • 2,714 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
-0.010(2.35%) |
Mkt cap ! $170.3M | |||
| Open | High | Low | Value | Volume |
| 43.0¢ | 43.5¢ | 41.0¢ | $128.3K | 304.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11249 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 43596 | 1 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |